Mollie Chipman, PhD, currently serves as the Associate Director of Business Development and Operations at GondolaBio, a position they began in 2025. Previously, they were a Project Leader and Consultant at Boston Consulting Group in 2025. Mollie completed a PhD in Oncology and Cancer Biology at the Gerstner Sloan-Kettering Graduate School, where they led research on Glioblastoma and received the NIH Ruth L. Kirschstein NRSA F31 Predoctoral Fellowship. Additionally, they gained experience as a Business Development Intern at Sparian Biosciences and a Project Leader at The Solution Lab, Inc., as well as a Research Assistant at Tufts University School of Medicine.
Location
New York City Metropolitan Area, United States
This person is not in any offices